Log in to save to my catalogue

A retrospect study based on real-world data to observe metabolic function in cancer patients using a...

A retrospect study based on real-world data to observe metabolic function in cancer patients using a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_443f77f6960c4f1e810845f0008f9ba5

A retrospect study based on real-world data to observe metabolic function in cancer patients using albumin-bound paclitaxel

About this item

Full title

A retrospect study based on real-world data to observe metabolic function in cancer patients using albumin-bound paclitaxel

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-06, Vol.13 (1), p.9028-9028, Article 9028

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

There is substantial evidence that albumin-bound paclitaxel (nab-paclitaxel) is effective and safe for the treatment of breast, lung and pancreatic cancers. However, it can still cause adverse effects by affecting cardiac enzymes, hepatic enzyme metabolism and blood routine related indicators, which affects the use of chemotherapy for a full course...

Alternative Titles

Full title

A retrospect study based on real-world data to observe metabolic function in cancer patients using albumin-bound paclitaxel

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_443f77f6960c4f1e810845f0008f9ba5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_443f77f6960c4f1e810845f0008f9ba5

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-35992-x

How to access this item